799 related articles for article (PubMed ID: 16756048)
21. Factors associated with the development of motor fluctuations and dyskinesias in Parkinson disease.
Hauser RA; McDermott MP; Messing S
Arch Neurol; 2006 Dec; 63(12):1756-60. PubMed ID: 17172616
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors associated with the development of motor complications in Parkinson's disease. A study in a Chilean population].
Juri-Claveria C; Aguirre-M C; Viviani-G P; Chana-Cuevas P
Rev Neurol; 2007 Jul 16-31; 45(2):77-80. PubMed ID: 17642046
[TBL] [Abstract][Full Text] [Related]
23. Motor complications of Parkinson's disease.
Martignoni E; Riboldazzi G; Calandrella D; Riva N
Neurol Sci; 2003 May; 24 Suppl 1():S27-9. PubMed ID: 12774208
[TBL] [Abstract][Full Text] [Related]
24. Levodopa in the early treatment of Parkinson's disease.
Murata M
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S17-20. PubMed ID: 19131036
[TBL] [Abstract][Full Text] [Related]
25. Clinical course of patients with idiopathic Parkinson's disease.
Roos RA; Jongen JC; van der Velde EA
Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Parkinson's disease in Northern Jordan.
Alrefai A; Habahbih M; Alkhawajah M; Darwish M; Batayha W; Khader Y; El-Salem K
Clin Neurol Neurosurg; 2009 Dec; 111(10):812-5. PubMed ID: 19733962
[TBL] [Abstract][Full Text] [Related]
27. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease.
McColl CD; Reardon KA; Shiff M; Kempster PA
Mov Disord; 2002 Nov; 17(6):1227-34. PubMed ID: 12465061
[TBL] [Abstract][Full Text] [Related]
28. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
[TBL] [Abstract][Full Text] [Related]
29. [Systematic evaluation on influence of dopaminergic therapy: on motor complications in Parkinson's disease].
Zhou MZ; Liu ZG; Chen W; Lu LX; Wu JY; Qi C
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(7):438-44. PubMed ID: 19567089
[TBL] [Abstract][Full Text] [Related]
30. Bilateral posteroventral pallidotomy in advanced Parkinson's disease in three patients.
Schuurman PR; de Bie RM; Speelman JD; Bosch DA
Mov Disord; 1997 Sep; 12(5):752-5. PubMed ID: 9380060
[TBL] [Abstract][Full Text] [Related]
31. [Fluctuations and dyskinesias as early L-dopa-induced motor complications in severe Parkinsonian's patients].
Vaamonde J; Ibáñez R; Gudín M; Hernández A
Neurologia; 2003 Apr; 18(3):162-5. PubMed ID: 12677484
[TBL] [Abstract][Full Text] [Related]
32. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic treatment of advanced Parkinson's disease: a meta-analysis of COMT inhibitors and MAO-B inhibitors.
Talati R; Reinhart K; Baker W; White CM; Coleman CI
Parkinsonism Relat Disord; 2009 Aug; 15(7):500-5. PubMed ID: 19167259
[TBL] [Abstract][Full Text] [Related]
34. Ten-year follow-up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa.
Hauser RA; Rascol O; Korczyn AD; Jon Stoessl A; Watts RL; Poewe W; De Deyn PP; Lang AE
Mov Disord; 2007 Dec; 22(16):2409-17. PubMed ID: 17894339
[TBL] [Abstract][Full Text] [Related]
35. Recognition and treatment of response fluctuations in Parkinson's disease: review article.
Verhagen Metman L
Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528
[TBL] [Abstract][Full Text] [Related]
36. Effect of bilateral subthalamic nucleus stimulation on levodopa-unresponsive axial symptoms in Parkinson's disease.
Yamada K; Goto S; Hamasaki T; Kuratsu JI
Acta Neurochir (Wien); 2008 Jan; 150(1):15-22; discussion 22. PubMed ID: 18180867
[TBL] [Abstract][Full Text] [Related]
37. Gait analysis in patients with Parkinson's disease and motor fluctuations: influence of levodopa and comparison with other measures of motor function.
O'Sullivan JD; Said CM; Dillon LC; Hoffman M; Hughes AJ
Mov Disord; 1998 Nov; 13(6):900-6. PubMed ID: 9827613
[TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori infection and motor fluctuations in patients with Parkinson's disease.
Lee WY; Yoon WT; Shin HY; Jeon SH; Rhee PL
Mov Disord; 2008 Sep; 23(12):1696-700. PubMed ID: 18649391
[TBL] [Abstract][Full Text] [Related]
39. [Motor complications in patients with Parkinson disease treated with levodopa].
Luquin MR; Obeso JA; Martínez-Lage JM
Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
[TBL] [Abstract][Full Text] [Related]
40. Initial therapy for Parkinson's disease: levodopa vs. dopamine receptor agonists.
Kondo T
J Neurol; 2002 Sep; 249 Suppl 2():II25-9. PubMed ID: 12375060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
